Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Elevai Labs, Inc. - Common Stock
(NQ:
ELAB
)
0.3250
+0.0050 (+1.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Elevai Labs, Inc. - Common Stock
< Previous
1
2
Next >
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum
August 26, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
August 26, 2024
Via
Benzinga
Why Workday Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
August 23, 2024
Via
Benzinga
ELAB Stock Earnings: Elevai Labs Reported Results for Q2 2024
August 14, 2024
Elevai Labs just reported results for the second quarter of 2024.
Via
InvestorPlace
ELAB Stock Earnings: Elevai Labs Reported Results for Q1 2024
May 15, 2024
Elevai Labs just reported results for the first quarter of 2024.
Via
InvestorPlace
ELAB Stock Earnings: Elevai Labs Reported Results for Q4 2023
April 02, 2024
Elevai Labs just reported results for the fourth quarter of 2023.
Via
InvestorPlace
Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health Applications
August 19, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD
July 30, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 25, 2024
Via
Benzinga
Top 4 Risk Off Stocks You'll Regret Missing In July
July 16, 2024
Via
Benzinga
Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line
June 28, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024
June 26, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs
June 14, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm
May 29, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference
May 22, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries
May 17, 2024
Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries
Via
News Direct
Elevai Labs Inc. Reports First Quarter 2024 Financial Results
May 15, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
May 02, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
12 Consumer Staples Stocks Moving In Wednesday's After-Market Session
May 01, 2024
Via
Benzinga
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare
May 01, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
May 01, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments
April 29, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months
April 22, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
April 09, 2024
Via
Benzinga
Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results
March 29, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
March 18, 2024
ELEVAI Physician-Dispensed Skincare Now Available Direct to Consumers
From
Elevai Labs Inc.
Via
GlobeNewswire
Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
February 22, 2024
Shares of NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 22, 2024
Pre-market stock movers are a hot topic on Thursday and we're starting the day with a breakdown of all the latest news this morning!
Via
InvestorPlace
Why Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
February 06, 2024
Shares of Palantir Technologies Inc. (NYSE: PLTR) rose sharply during today’s pre-market trading after the company reported better-than-expected fourth-quarter sales results and issued guidance.
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.